ProCell Therapies, LLC

ProCell Therapies is a medical device and biotech company specializing in advanced microchanneling (microneedling) technology and stem cell-derived growth factor serums for professional skin rejuvenation. Founded in 2014 by Dr. Mitchell Schwartz with over 30 years of dermatology expertise, ProCell develops non-invasive aesthetic solutions targeting fine lines, acne scarring, and sun damage. The company's proprietary microchanneling devices create thousands of controlled microchannels in the skin, stimulating natural collagen production and cellular renewal. Complementary growth factor serums, formulated with regenerative proteins from mesenchymal stem cells, enhance absorption and accelerate healing when applied post-treatment. ProCell markets both professional (MD/physician) and practitioner (PRO/aesthetician) device tiers and offers comprehensive aftercare product lines. With over 1.45 million treatments performed globally across 41 countries and strong clinical validation, ProCell serves dermatologists, aesthetic practitioners, medical spas, and skincare professionals seeking minimally invasive, clinically proven skin rejuvenation technologies.